Skip to main content
Clinical Trials/NCT05912764
NCT05912764RecruitingNot Applicable

Evaluation of Early Home Return Care Pathway in Patients Who Have Undergone Endoscopic Enucleation of Prostate Adenoma by Laser

GCS Ramsay Santé pour l'Enseignement et la Recherche2 sites in 1 country440 target enrollmentStarted: January 26, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
440
Locations
2
Primary Endpoint
Re-hospitalizations and/or hospitalization extensions rate

Study Overview

Brief Summary

Prostate adenoma management includes, if necessary, surgical treatments: resection or vaporization by endoscopy or by open surgery in case of a very large prostate. Laser technology is a curative treatment for prostate adenoma. The minimum duration of hospitalization, in the context of enucleation prostatic endoscopy by laser, is estimated at 48 hours.

The Union Clinique has developed an improved rehabilitation care pathway reducing hospitalization duration to 24 hours (one night hospitalization). This care pathway involves patient as an actor in its care but also health professionals, in particular nurses.

This study is based on the hypothesis that the model developed by the Union Clinique can be translated to other healthcare establishments and that home return supervized by nurses allows reducing hospital stay length without increasing the risk of serious complications for patients

Detailed Description

Prostate adenoma management includes first drug treatments and, if necessary, surgical treatments: resection or vaporization by endoscopy or by open surgery in case of a very large prostate. Laser technology is a curative treatment for prostate adenoma. Its objective is to perform endoscopic excision (ablation) of the adenoma, in order to improve patients' quality of life and their urination. The laser energy is transmitted by a guided fiber under endoscopic control through the urethral canal in contact with the adenoma. Several wavelengths of the laser beam, depending on the nature of the generator crystals, are used for their specificity in cutting and tissue cauterization: Greenlight laser, Holmium laser, Thulium laser.

The minimum duration of hospitalization, in the context of an enucleation prostatic endoscopy by laser, is estimated at 48 hours. The Union Clinique has developed an improved rehabilitation care pathway reducing hospitalization duration to 24 hours (one night hospitalization). This care pathway involves patient as an actor in its care but also health professionals, in particular nurses, who will coordinate patients care prior to their intervention and when they leave the Clinics.

This study is based on the hypothesis that the model developed by the Union Clinique can be translated to other healthcare establishments and that home return supervized by health professionals, notably nurses, allows reducing hospital stay length without increasing the risk of serious complications for patients

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
45 Years to — (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patient planned for endoscopic enucleation of prostate adenoma with laser
  • Patient with symptomatic benign prostatic hyperplasia and refractory to medical reatment and/or
  • Patient with benign prostatic hyperplasia complicated by chronic retention of urine and/or
  • Patient with benign prostatic hyperplasia complicated by prostatitis and/or
  • Patient with symptomatic benign prostatic hyperplasia

Exclusion Criteria

  • Patient living beyond the scope of care by the nurses coordination
  • Bedridden patient or WHO clinical condition >2
  • Patient requiring curative anticoagulation which cannot be interrupted or relayed at home by heparin
  • Patient with double anti-platelet aggregation who cannot be interrupted

Outcomes

Primary Outcomes

Re-hospitalizations and/or hospitalization extensions rate

Time Frame: 2 weeks

the percentage of re-hospitalizations and/or hospitalization extensions

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials